These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26845951)

  • 1. [Prevention of recurrence of hepatocellular carcinoma with anti-viral therapy for hepatitis C virus].
    Aikata H; Chayama K
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():311-5. PubMed ID: 26845951
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does interferon therapy on type C liver cirrhosis prevent the occurrence of hepatocellular carcinoma?].
    Harada H; Iga D; Arisaka Y; Mitsuhashi Y; Kamitsukasa H; Yagura M; Endou H; Kawashima H
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):754-8. PubMed ID: 7563870
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
    Yoshida H; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].
    Kubo S; Nishiguchi S; Hirohashi K; Tanaka H; Shuto T; Takemura S; Shiomi S; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):1975-9. PubMed ID: 11791377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention for the development of hepatitis B virus-related hepatocellular carcinoma by anti-viral treatment].
    Ebinuma H; Saito H
    Nihon Rinsho; 2011 May; 69 Suppl 4():540-5. PubMed ID: 22096977
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon and hepatocellular carcinoma.
    Koretz RL
    Lancet; 1996 Jan; 347(8995):194-5. PubMed ID: 8544565
    [No Abstract]   [Full Text] [Related]  

  • 8. Can therapy of hepatitis C affect the development of hepatocellular carcinoma?
    Kulik LM
    J Natl Compr Canc Netw; 2006 Sep; 4(8):751-7. PubMed ID: 16948953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of novel beta-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma.
    Bridges EG; Cheng YC
    Prog Liver Dis; 1995; 13():231-45. PubMed ID: 9224504
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hepatitis B and C -- current standards].
    Zeuzem S
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S57-9. PubMed ID: 15368169
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].
    Nishiguchi S; Kubo S; Shiomi S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):600-4. PubMed ID: 15359868
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cost-effectiveness of antiviral therapy for chronic hepatitis C patients in prevention of hepatocellular cancer ].
    Yoshida H; Tateishi R; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):511-4. PubMed ID: 15359852
    [No Abstract]   [Full Text] [Related]  

  • 13. Does interferon therapy prevent hepatocellular carcinoma in patients with chronic hepatitis C?
    Kowdley KV
    Gastroenterology; 1999 Sep; 117(3):738-9. PubMed ID: 10464154
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.
    Xu J; Li J; Chen J; Liu ZJ
    Adv Clin Exp Med; 2015; 24(2):331-40. PubMed ID: 25931368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon therapy reduces the risk for hepatocellular carcinoma.
    Brown JL
    Gut; 2000 Nov; 47(5):610-1. PubMed ID: 11034573
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoprevention of hepatocellular carcinoma in hepatitis C virus-related cirrhosis: first, eliminate the virus.
    Valla DC; Degos F
    J Hepatol; 2001 Apr; 34(4):606-9. PubMed ID: 11394663
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of hepatocellular carcinoma.
    Stark JJ
    Ann Intern Med; 2004 Jul; 141(1):77; author reply 77-8. PubMed ID: 15238378
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined interferon, ribavirin treatment and the occurrence of hepatocellular carcinoma].
    Lengyel G; Fehér J
    Orv Hetil; 2010 Jul; 151(29):1177-81. PubMed ID: 20591786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C and interferon: fewer cases of liver cancer.
    Prescrire Int; 2013 Jul; 22(140):191. PubMed ID: 23951600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon: benefit beyond hepatitis therapy?
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2001 Dec; 96(12):3435-6. PubMed ID: 11774964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.